Autor/in Curigliano, G Fallowfield, L 1 Gligorov, J 1 Jenkins, V 1 Knoop, A 1 Müller, V Osborne, S 1 Pivot, X 1 Scotto, N 1 Verma, S alle zeigenListe einklappen
Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study Pivot, X Gligorov, J Müller, V Curigliano, G Knoop, A Verma, S Jenkins, V 2014 - Forschungsinformationssystem des UKE
